Foghorn Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FHTX and other ETFs, options, and stocks.About FHTX
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.
CEOAdrian Gottschalk
CEOAdrian Gottschalk
Employees112
Employees112
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees112
Employees112
FHTX Key Statistics
Market cap295.76M
Market cap295.76M
Price-Earnings ratio-4.21
Price-Earnings ratio-4.21
Dividend yield—
Dividend yield—
Average volume157.11K
Average volume157.11K
High today$5.54
High today$5.54
Low today$5.13
Low today$5.13
Open price$5.14
Open price$5.14
Volume391.64K
Volume391.64K
52 Week high$6.79
52 Week high$6.79
52 Week low$2.94
52 Week low$2.94
Stock Snapshot
Foghorn Therapeutics(FHTX) stock is priced at $5.24, giving the company a market capitalization of 295.76M. It carries a P/E multiple of -4.21.
During the trading session on 2025-12-19, Foghorn Therapeutics(FHTX) shares reached a daily high of $5.54 and a low of $5.13. At a current price of $5.24, the stock is +2.1% higher than the low and still -5.4% under the high.
Trading volume for Foghorn Therapeutics(FHTX) stock has reached 391.64K, versus its average volume of 157.11K.
The stock's 52-week range extends from a low of $2.94 to a high of $6.79.
The stock's 52-week range extends from a low of $2.94 to a high of $6.79.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own FHTX. This list is generated using Robinhood data, and it’s not a recommendation.